Search the Newsroom
Filter By
Showing 791 - 800 of 2907 results
Early Life Breakthroughs - Advancing Child Development & Behavioral Health in Low- and Middle-Income Countries
Here are resources to help frontline clinicians diagnose and manage developmental disorders and behavioral concerns.
Mindfulness: A Useful Coping Strategy
Youth with chronic conditions like spina bifida and their families can experience high levels of stress.
Updates from the Spina Bifida Program
An update on our first Education Day in November and more.
CHOP OPEN: Course Presentations
Click through our online courses to learn more about the latest advances in pediatric care, clinical educational resources and more.
CHOP Experts Share Cutting-Edge Innovations at Arab Health Exhibition
Showcasing its longstanding partnership with the United Arab Emirates (UAE) Emirates Health Services (EHS), Children’s Hospital of Philadelphia (CHOP) will exhibit thought-leading clinical research in the EHS booth at the Arab Health 2023 Exhibition and Congress, taking place this week in Dubai.
News & Views: SARS-Cov-2 Is Not the Only Virus to Cause Lingering Effects
Find out about the lingering effects of Epstein-Barr virus, streptococcus, influenza, pneumococcus, Ebola, polio, measles and other infections as well as what to consider in relation to long COVID.
In the Journals: Admitted with or for COVID-19? Why It Matters.
The findings of this recent study underline the importance of accurate public health reporting as we make decisions about vaccines moving forward. Check it out.
Technically Speaking: Why HPV Vaccination Before Age 11 Years Is a Good Idea
Dr. Sean O’Leary, Chair of AAP’s COID, explains why AAP and CDC recommendations about HPV vaccine differ.
Vaccine Resources: On-demand Learning
Check out these learning opportunities from ACOG, NFID, Voices for Vaccines and more, some of which include continuing education credits.
CHOP Will Be Provider in Independence Blue Cross’s Gene Therapy Network
CHOP will be a provider in Independence Blue Cross’s new Advanced Network for Gene-Based Therapeutics, effective March 1, 2023.